世界の認知症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dementia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4106
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、認知症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ドネペジル、メマンチン、リバスチグミン、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・認知症治療の市場動向
・企業の競争状況、市場シェア
・認知症治療の種類別市場規模と予測2016-2027（ドネペジル、メマンチン、リバスチグミン、その他）
・認知症治療の用途別市場規模と予測2016-2027（病院、ドラッグストア、その他）
・認知症治療の北米市場規模2016-2027（アメリカ、カナダ）
・認知症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・認知症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・認知症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・認知症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck）
・結論

Donepezil (also known as Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are used to treat the symptoms of mild to moderate Alzheimer’s disease.

Market Analysis and Insights: Global Dementia Treatment Market
The global Dementia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dementia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dementia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dementia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dementia Treatment market.

Global Dementia Treatment Scope and Market Size
Dementia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dementia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Donepezil
Memantine
Rivastigmine
Others

Segment by Application
Hospitals
Drugstores
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Dementia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dementia Treatment Market Perspective (2016-2027)
2.2 Dementia Treatment Growth Trends by Regions
2.2.1 Dementia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dementia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dementia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dementia Treatment Industry Dynamic
2.3.1 Dementia Treatment Market Trends
2.3.2 Dementia Treatment Market Drivers
2.3.3 Dementia Treatment Market Challenges
2.3.4 Dementia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dementia Treatment Players by Revenue
3.1.1 Global Top Dementia Treatment Players by Revenue (2016-2021)
3.1.2 Global Dementia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dementia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dementia Treatment Revenue
3.4 Global Dementia Treatment Market Concentration Ratio
3.4.1 Global Dementia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia Treatment Revenue in 2020
3.5 Dementia Treatment Key Players Head office and Area Served
3.6 Key Players Dementia Treatment Product Solution and Service
3.7 Date of Enter into Dementia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dementia Treatment Breakdown Data by Type
4.1 Global Dementia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dementia Treatment Forecasted Market Size by Type (2022-2027)

5 Dementia Treatment Breakdown Data by Application
5.1 Global Dementia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dementia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dementia Treatment Market Size (2016-2027)
6.2 North America Dementia Treatment Market Size by Type
6.2.1 North America Dementia Treatment Market Size by Type (2016-2021)
6.2.2 North America Dementia Treatment Market Size by Type (2022-2027)
6.2.3 North America Dementia Treatment Market Size by Type (2016-2027)
6.3 North America Dementia Treatment Market Size by Application
6.3.1 North America Dementia Treatment Market Size by Application (2016-2021)
6.3.2 North America Dementia Treatment Market Size by Application (2022-2027)
6.3.3 North America Dementia Treatment Market Size by Application (2016-2027)
6.4 North America Dementia Treatment Market Size by Country
6.4.1 North America Dementia Treatment Market Size by Country (2016-2021)
6.4.2 North America Dementia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dementia Treatment Market Size (2016-2027)
7.2 Europe Dementia Treatment Market Size by Type
7.2.1 Europe Dementia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dementia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dementia Treatment Market Size by Type (2016-2027)
7.3 Europe Dementia Treatment Market Size by Application
7.3.1 Europe Dementia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dementia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dementia Treatment Market Size by Application (2016-2027)
7.4 Europe Dementia Treatment Market Size by Country
7.4.1 Europe Dementia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dementia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dementia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dementia Treatment Market Size by Type
8.2.1 Asia-Pacific Dementia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dementia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dementia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dementia Treatment Market Size by Application
8.3.1 Asia-Pacific Dementia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dementia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dementia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dementia Treatment Market Size by Region
8.4.1 Asia-Pacific Dementia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dementia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dementia Treatment Market Size (2016-2027)
9.2 Latin America Dementia Treatment Market Size by Type
9.2.1 Latin America Dementia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dementia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dementia Treatment Market Size by Type (2016-2027)
9.3 Latin America Dementia Treatment Market Size by Application
9.3.1 Latin America Dementia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dementia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dementia Treatment Market Size by Application (2016-2027)
9.4 Latin America Dementia Treatment Market Size by Country
9.4.1 Latin America Dementia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dementia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dementia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dementia Treatment Market Size by Type
10.2.1 Middle East & Africa Dementia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dementia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dementia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dementia Treatment Market Size by Application
10.3.1 Middle East & Africa Dementia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dementia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dementia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dementia Treatment Market Size by Country
10.4.1 Middle East & Africa Dementia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dementia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Dementia Treatment Introduction
11.1.4 Allergan Revenue in Dementia Treatment Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Dementia Treatment Introduction
11.2.4 Eisai Revenue in Dementia Treatment Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dementia Treatment Introduction
11.3.4 Novartis Revenue in Dementia Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Details
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Dementia Treatment Introduction
11.4.4 Daiichi Sankyo Revenue in Dementia Treatment Business (2016-2021)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Details
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Dementia Treatment Introduction
11.5.4 Merz Pharma Revenue in Dementia Treatment Business (2016-2021)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Dementia Treatment Introduction
11.6.4 Pfizer Revenue in Dementia Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Dementia Treatment Introduction
11.7.4 Johnson & Johnson Revenue in Dementia Treatment Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Details
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Dementia Treatment Introduction
11.8.4 Lundbeck Revenue in Dementia Treatment Business (2016-2021)
11.8.5 Lundbeck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dementia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Donepezil
Table 3. Key Players of Memantine
Table 4. Key Players of Rivastigmine
Table 5. Key Players of Others
Table 6. Global Dementia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dementia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Dementia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Dementia Treatment Market Share by Regions (2016-2021)
Table 10. Global Dementia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Dementia Treatment Market Share by Regions (2022-2027)
Table 12. Dementia Treatment Market Trends
Table 13. Dementia Treatment Market Drivers
Table 14. Dementia Treatment Market Challenges
Table 15. Dementia Treatment Market Restraints
Table 16. Global Dementia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Dementia Treatment Market Share by Players (2016-2021)
Table 18. Global Top Dementia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia Treatment as of 2020)
Table 19. Ranking of Global Top Dementia Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Dementia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Dementia Treatment Product Solution and Service
Table 23. Date of Enter into Dementia Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Dementia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Dementia Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Dementia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Dementia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Dementia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Dementia Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Dementia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Dementia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Dementia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Dementia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Dementia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Dementia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Dementia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Dementia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Dementia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Dementia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Dementia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Dementia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Dementia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Dementia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dementia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dementia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dementia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Dementia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Dementia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Dementia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Dementia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Dementia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Dementia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Dementia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Dementia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Dementia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dementia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dementia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dementia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Dementia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Dementia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Dementia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Dementia Treatment Product
Table 66. Allergan Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. Eisai Company Details
Table 69. Eisai Business Overview
Table 70. Eisai Dementia Treatment Product
Table 71. Eisai Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 72. Eisai Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Dementia Treatment Product
Table 76. Novartis Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Daiichi Sankyo Company Details
Table 79. Daiichi Sankyo Business Overview
Table 80. Daiichi Sankyo Dementia Treatment Product
Table 81. Daiichi Sankyo Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 82. Daiichi Sankyo Recent Development
Table 83. Merz Pharma Company Details
Table 84. Merz Pharma Business Overview
Table 85. Merz Pharma Dementia Treatment Product
Table 86. Merz Pharma Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 87. Merz Pharma Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Dementia Treatment Product
Table 91. Pfizer Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Dementia Treatment Product
Table 96. Johnson & Johnson Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. Lundbeck Company Details
Table 99. Lundbeck Business Overview
Table 100. Lundbeck Revenue in Dementia Treatment Business (2016-2021) & (US$ Million)
Table 101. Lundbeck Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dementia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Donepezil Features
Figure 3. Memantine Features
Figure 4. Rivastigmine Features
Figure 5. Others Features
Figure 6. Global Dementia Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Drugstores Case Studies
Figure 9. Others Case Studies
Figure 10. Dementia Treatment Report Years Considered
Figure 11. Global Dementia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Dementia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Dementia Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Dementia Treatment Market Share by Regions (2022-2027)
Figure 15. Global Dementia Treatment Market Share by Players in 2020
Figure 16. Global Top Dementia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Dementia Treatment Revenue in 2020
Figure 18. Global Dementia Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Dementia Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Dementia Treatment Market Share by Type (2016-2027)
Figure 22. North America Dementia Treatment Market Share by Application (2016-2027)
Figure 23. North America Dementia Treatment Market Share by Country (2016-2027)
Figure 24. United States Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Dementia Treatment Market Share by Type (2016-2027)
Figure 28. Europe Dementia Treatment Market Share by Application (2016-2027)
Figure 29. Europe Dementia Treatment Market Share by Country (2016-2027)
Figure 30. Germany Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Dementia Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Dementia Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Dementia Treatment Market Share by Region (2016-2027)
Figure 40. China Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Dementia Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Dementia Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Dementia Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Dementia Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Dementia Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Dementia Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Dementia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 60. Eisai Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 63. Merz Pharma Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 66. Lundbeck Revenue Growth Rate in Dementia Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の色汗症治療市場規模・現状・予測（2021年-2027年） Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless…
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…
世界のOAB治療市場規模・現状・予測（2021年-2027年） This repor mainly studies OAB (overactive bladder) treatment market. Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder con…
世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年） Choledocholithiasis is a condition wherein gall stones are found in the common bile duct instead of the gall bladder. Market Analysis and Insights: Global Choledocholithiasis Treatment Market The global Choledocholithiasis Treatment market size is projected to reach US$ XX million by 2027, from US$ …